Características clínicas y evolutivas de una población con herpes zoster diseminado: un estudio de cohorte retrospectiva

Bollea-Garlatti, ML; Bollea-Garlatti, LA; Vacas, AS; Torre, AC; Kowalczuk, AM; Galimberti, RL; Ferreyro, BL.
Actas dermo-sifiliogr. (Ed. impr.) ; 108(2): 145-152, mar. 2017. tab, ilus, graf
Artigo Espanhol | IBECS (Espanha) | ID: ibc-160862

Documentos relacionados

  1. Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review.
  2. A rare case of herpes zoster triggered by a non-live varicella vaccine.
  3. Interplay between stress and immunity triggers herpes zoster infection in COVID-19 patients: a review.
  4. Zoster vaccine in immunosuppressed populations.
  5. Central Nervous System Infections in Immunocompromised Patients.
  6. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program.
  7. Severe and Complicated Varicella and Associated Genotypes 10 Years After Introduction of a One-Dose Varicella Vaccine Program.
  8. Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions.
  9. Immunity to Invasive Fungal Diseases.
  10. Low complication rate in immunocompromised children with varicella-zoster virus infections in a single centre.